DOI: https://doi.org/10.22141/1997-2938.3.34.2017.115734

Malabsorption syndrome and microbial flora in patients with stoma

V.I. Rusyn, G.M. Koval, F.M. Pavuk, Yu.S. Lozynskyi, O.V. Leoshyk

Abstract


Background. Microbiological studies of ostomy gut areas are relevant for the selection of adequate methods for the prevention of purulent-septic complications during reconstructive surgeries on the small and large intestine. Our purpose was to investigate the malabsorption syndrome and to give a description of the microflora of the gastrointestinal tract of the patients with stoma. Materials and methods. Microbiological research and analysis of coprograms were performed in 29 patients with stoma. According to the level (localization) of stoma the patients are divided into 3 groups: group I — 7 patients with ileostomy in inflammatory bowel diseases (ulcerative colitis, Crohn’s disease); group II — 9 individuals with ascending colostomy (two with cecostomy, in 7 — at the hepatic level of the colon); group III — 13 patients with descending colostomy. Patients in groups II and III underwent surgeries for obstructive cancer with acute intestinal obstruction. Results. It was found that in patients with ileocolostomy, pH of feces exceeded 5.5 only in one case; fiber, starch, neutral fat and fatty acids, muscle fibers, mucus, leukocytes were observed in a much higher number than in patients with colostomy. Muscle fibers were detected in 72 % of patients, fat — in 52 %, starch — in 72 %. In patients with descending colostomy: muscle fibers were found only in 20 % of cases, fat and fatty acids — in 20 %, starch — only in 34.5 % of patients. Anaerobic imbalance was diagnosed in all patients with stoma due to increased level of clostridia and opportunistic microflora. Conclusions. Patients with stoma have malabsorption syndrome that is most pronounced in ileostomy, the least pronounced in descending colostomy.

Keywords


malabsorption; colostomy; microflora

References


Бабак О.Я. Синдром дисбіотичних порушень мікрофлори кишечника: сучасний погляд на проблему / О.Я. Бабак // Сімейна медицина. — 2006. — № 2. — С. 4-6.

Винник Ю.А. Состояние обмена мелатонина у больных колоректальным раком и его прогностическое значение в патогенетическом лечении / Ю.А. Винник, С.В. Перепадя, В.И. Жуков, О.В. Зайцева // Вісник проблем біології і медицини. — 2009. — Вип 2. — С. 49-52.

Жуков В.И. Прогностическое значение серотонина в диагностике стадии заболевания и эффективности патогенетического лечения колоректального рака / В.И. Жуков, С.В. Перепадя, Ю.А. Винник, О.В. Зайцева // Проблеми екології та медицини. — 2009. — Т. 13, № 3–4. — С. 20-22.

Banerjee B. Nutritional Management of Digestive Di­sorders / B. Banerjee. — Taylor and Francis Group USA, LLC, 2011. — P. 128-138.

Bayless T. Advance therapy of inflammatory bowel di­sease / T. Bayless, S. Hanauer. — Volume I: Ulcerative colitis. — PMPH USA, 2011. — P. 465-470.

Matarese L. Bacteria-induced disease with bacteria / L. Matarese // Nutricition in clinical practice. — 2012. — Vol. 27. — P. 242-246.




Copyright (c) 2017 UKRAINIAN JOURNAL OF SURGERY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта